Back to results
US 10,882,829 B2Granted
Pharmaceutical compounds
AssigneeSareum Limited
InventorJohn Charles Reader
Life of this patent
Estimating the term…
Abstract
The invention provides a method of inhibiting a TYK2 kinase, which method comprises bringing into contact with the TYK2 kinase an effective TYK2 kinase-inhibiting amount of a compound having the formula (0): or a salt or stereoisomer thereof. The invention also provides a novel subset of compounds within formula (0) as well as pharmaceutical compositions containing them and their use in medicine.
Claims2
A compound which is 2-(2,6-dichloro-phenyl)-5-[4-(morpholine-4-carbonyl)-phenylamino]-oxazole-4-carboxylic acid amide, having the general formula:
- or a salt or tautomer thereof.
Dependencies are inferred from the claim text.